Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
191.49
-5.51 (-2.80%)
At close: May 6, 2026, 4:00 PM EDT
191.49
0.00 (0.00%)
After-hours: May 6, 2026, 4:25 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16 Jun '15 Jun '14 Jun '13
United States Revenue
249.12B220.99B225.23B
United States Revenue Growth
12.73%-1.88%10.71%
International Revenue
1.71B1.67B1.68B
International Revenue Growth
2.52%-0.71%3.96%
Revenue (Other)
-92.00M-84.00M-85.00M
Revenue (Total)
250.74B222.58B226.83B
Revenue (Total) Growth
12.65%-1.87%10.66%

Revenue Breakdown

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16 Jun '15 Jun '14 Jun '13
Pharmaceutical and Specialty Solutions Revenue
231.36B204.64B210.02B
Pharmaceutical and Specialty Solutions Revenue Growth
13.05%-2.56%11.23%
Global Medical Products and Distribution Revenue
12.79B12.64B12.38B
Global Medical Products and Distribution Revenue Growth
1.22%2.06%1.30%
Other Segment Revenue
6.68B5.38B4.51B
Other Segment Revenue Growth
24.12%19.28%12.21%
Revenue (Other)
-92.00M-84.00M-85.00M
Revenue (Total)
250.74B222.58B226.83B
Revenue (Total) Growth
12.65%-1.87%10.66%

EBIT

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16 Jun '15 Jun '14 Jun '13
Pharmaceutical and Specialty Solutions Segment Profit
2.67B2.26B2.02B
Pharmaceutical and Specialty Solutions Segment Profit Growth
18.38%12.06%7.12%
Global Medical Products and Distribution Segment Profit
178.00M135.00M92.00M
Global Medical Products and Distribution Segment Profit Growth
31.85%46.74%-
Other Segment Profit
684.00M516.00M423.00M
Other Segment Profit Growth
32.56%21.99%6.82%
Corporate Profit
-1.22B-634.00M-1.29B
Operating Income (Total)
2.31B2.28B1.24B
Operating Income (Total) Growth
1.63%83.03%65.29%

EBIT 2

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16 Jun '15 Jun '14 Jun '13
Corporate Profit
-1.22B-634.00M-1.29B
Operating Income (Total)
2.31B2.28B1.24B
Operating Income (Total) Growth
1.63%83.03%65.29%
Updated Apr 30, 2026. Data Source: Fiscal.ai.